Benchmarking Glaucoma
What does analysis of the last five years of literature on glaucoma tell us about the priorities of the field and the major contributors to it?
Glaucoma is second leading cause of blindness globally, after cataracts, but provides an even greater challenge: glaucoma-related blindness is permanent. This is a major driving factor for clinical research into glaucoma therapies.
To provide insight into the past and predictions for the future of the field, a series of metrics were applied to the last five years of the published literature. We asked:
- What are the major topics for the field?
- Which publications have the greatest impact?
- How is the knowledge available online?
- Who are the most prolific authors?
PubMed, was searched for glaucoma* with results limited to the last five years, in humans (for a clinical focus). The data were analyzed in Microsoft Excel 2013.
I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.